1. Home
  2. ABCL vs SDHC Comparison

ABCL vs SDHC Comparison

Compare ABCL & SDHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABCL
  • SDHC
  • Stock Information
  • Founded
  • ABCL 2012
  • SDHC 2008
  • Country
  • ABCL Canada
  • SDHC United States
  • Employees
  • ABCL N/A
  • SDHC N/A
  • Industry
  • ABCL Biotechnology: Pharmaceutical Preparations
  • SDHC
  • Sector
  • ABCL Health Care
  • SDHC
  • Exchange
  • ABCL Nasdaq
  • SDHC Nasdaq
  • Market Cap
  • ABCL 1.1B
  • SDHC 1.1B
  • IPO Year
  • ABCL 2020
  • SDHC 2024
  • Fundamental
  • Price
  • ABCL $5.93
  • SDHC $15.89
  • Analyst Decision
  • ABCL Strong Buy
  • SDHC Hold
  • Analyst Count
  • ABCL 5
  • SDHC 4
  • Target Price
  • ABCL $8.00
  • SDHC $17.88
  • AVG Volume (30 Days)
  • ABCL 6.2M
  • SDHC 112.1K
  • Earning Date
  • ABCL 11-06-2025
  • SDHC 11-11-2025
  • Dividend Yield
  • ABCL N/A
  • SDHC N/A
  • EPS Growth
  • ABCL N/A
  • SDHC N/A
  • EPS
  • ABCL N/A
  • SDHC N/A
  • Revenue
  • ABCL $32,875,999.00
  • SDHC $1,013,967,000.00
  • Revenue This Year
  • ABCL $16.99
  • SDHC $1.33
  • Revenue Next Year
  • ABCL $63.73
  • SDHC $8.36
  • P/E Ratio
  • ABCL N/A
  • SDHC N/A
  • Revenue Growth
  • ABCL N/A
  • SDHC 22.89
  • 52 Week Low
  • ABCL $1.89
  • SDHC $15.78
  • 52 Week High
  • ABCL $6.52
  • SDHC $39.46
  • Technical
  • Relative Strength Index (RSI)
  • ABCL 64.46
  • SDHC 32.04
  • Support Level
  • ABCL $5.57
  • SDHC $17.39
  • Resistance Level
  • ABCL $6.52
  • SDHC $17.40
  • Average True Range (ATR)
  • ABCL 0.39
  • SDHC 0.95
  • MACD
  • ABCL 0.09
  • SDHC -0.16
  • Stochastic Oscillator
  • ABCL 68.46
  • SDHC 1.63

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

About SDHC Smith Douglas Homes Corp.

Smith Douglas Homes Corp is a company engaged in the design, construction, and sale of single-family homes in some of the highest growth and desirable markets in the Southeastern United States. It is organized into eight geographical divisions which comprise two reportable segments. Its Southeast segment consists of Atlanta, Central Georgia, Charlotte, Greenville, and Raleigh divisions. Its Central segment consists of Alabama, Houston, and Nashville divisions.

Share on Social Networks: